Literature DB >> 15153321

CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme.

J F Nygård1, T Sauer, M Nygård, G B Skare, S Ø Thoresen.   

Abstract

OBJECTIVES: To estimate the risk of cervical intraepithelial neoplasia (CIN) 2/3 and invasive cervical cancer (ICC) in an organised screening programme after an unsatisfactory or a normal Pap smear.
SETTING: A seven-year prospective cohort study of the Norwegian population-based co-ordinated screening programme based on the actual diagnostic and screening procedures performed. Observations of 526,661 women with a normal index Pap smear and 21,405 women with an unsatisfactory index Pap smear were made during 3.26 million women-years.
METHODS: The risk of being diagnosed with CIN 2/3 or ICC was calculated by logistic regression for the first two years of follow-up. The hazard of being diagnosed with CIN 2/3 or ICC for the women who were not diagnosed during the two first years was estimated by non-parametrical survival regression.
RESULTS: After two years of follow-up, 0.2% of the women were diagnosed with CIN 2/3 and 0.01% with ICC after a normal Pap smear. An unsatisfactory Pap smear indicated a 1.6-4.0 times higher risk of harbouring a CIN 2/3 or ICC compared to women with a normal Pap smear. No increased risk of ICC was found during long-term follow-up for the 70% of the women with an unsatisfactory Pap smear who were returned to ordinary screening. Prior series of low-grade Pap smears followed by a normal Pap were associated with an increased risk of CIN 2/3 and ICC.
CONCLUSIONS: An unsatisfactory Pap smear indicates a risk of harbouring CIN II/III or ICC. Repeated Pap smears are adequate as a follow-up of an unsatisfactory Pap smear. Women with repeated series of equivocal/LSIL Pap smears followed by a normal Pap should be considered at high risk.

Entities:  

Mesh:

Year:  2004        PMID: 15153321     DOI: 10.1258/096914104774061047

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  5 in total

1.  [Colposcopy in the diagnosis of early cervical cancer].

Authors:  W Kühn
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

2.  Cervical human papillomavirus detection is not affected by menstrual phase.

Authors:  Joseph E Tota; Agnihotram V Ramanakumar; Salaheddin M Mahmud; Andrea Trevisan; Luisa L Villa; Eduardo L Franco
Journal:  Sex Transm Infect       Date:  2012-10-30       Impact factor: 3.519

3.  Performance of cytology and human papillomavirus testing in relation to the menstrual cycle.

Authors:  M E Sherman; J D Carreon; M Schiffman
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

4.  The potential of RNA as a target for national screening of pre-cancer.

Authors:  Frank Karlsen; Margaret Muturi; Cosmas Muyabwa; Lars E Roseng; Serge Bigabwa; Byamungu Chihongola; Lucy Muchiri
Journal:  J Public Health Afr       Date:  2018-12-21

Review 5.  Worldwide incidence of cervical lesions: a systematic review.

Authors:  J Ting; A F Rositch; S M Taylor; L Rahangdale; H M Soeters; X Sun; J S Smith
Journal:  Epidemiol Infect       Date:  2014-05-30       Impact factor: 4.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.